{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:02:48Z","timestamp":1779922968449,"version":"3.53.1"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioma represents the most prevalent and lethal primary malignant tumor of the central nervous system, characterized by remarkable cellular heterogeneity and poor prognosis. Comprehensive characterization of glioma at single-cell resolution is essential for identifying novel therapeutic targets and improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed comprehensive single-cell RNA sequencing (scRNA-seq) analysis on glioma samples obtained from the Gene Expression Omnibus (GEO) database. Advanced computational approaches including principal component analysis (PCA), uniform manifold approximation and projection (UMAP), t-distributed stochastic neighbor embedding (t-SNE), and differential expression analysis were employed to characterize cellular heterogeneity. Gene co-expression network construction and pathway enrichment analysis were conducted to identify functional modules. Candidate biomarkers were validated using quantitative real-time PCR (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA) in GL261 glioma cells, C8-D1A normal glial cells, and intervertebral disc nucleus pulposus cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Quality control analysis revealed high-quality single-cell data with median gene counts of 5,437 and UMI counts of 14,207 per cell. A total of 4,753 highly variable genes were identified, and 22 distinct cellular clusters were delineated using the Louvain algorithm. PCA loading analysis identified key contributing genes including cell cycle regulators (CDK1, TOP2A, BIRC5), immune-related genes (C1QA, C1QB, HLA-DRB6), and neural lineage markers (MOBP, MAG, GJB1). Cell type annotation identified seven major populations: astrocytes, oligodendrocytes, microglia, neural stem cells, OPC\/immature neurons, pericytes, and T cells. Differential expression analysis uncovered 847 upregulated and 652 downregulated genes (|log\n                      <jats:sub>2<\/jats:sub>\n                      FC| &amp;gt; 1, adjusted P &amp;lt; 0.05). Gene co-expression network analysis revealed five major functional modules centered on hub genes including CLEC12A, CLU, AQP4, and S100A16. Pathway enrichment demonstrated significant involvement of cell cycle, Notch signaling, MAPK pathway, and neurogenesis. Experimental validation confirmed that Plp1 was significantly downregulated in GL261 cells (0.38 \u00b1 0.05-fold, P &amp;lt; 0.01), while\n                      <jats:italic>F<\/jats:italic>\n                      th1 (2.15 \u00b1 0.28-fold, P &amp;lt; 0.001) and Gm42418 (5.67 \u00b1 0.52-fold, P &amp;lt; 0.001) were markedly upregulated compared to normal glial cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This comprehensive single-cell transcriptomic analysis successfully characterized the cellular heterogeneity of glioma, identifying distinct cell populations and molecular signatures. PLP1, FTH1, and GM42418 were validated as potential molecular biomarkers, providing novel insights into glioma pathogenesis and potential therapeutic targets.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fgene.2026.1818742","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:10:26Z","timestamp":1779919826000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell transcriptomic profiling uncovers key molecular signatures in glioma pathogenesis"],"prefix":"10.3389","volume":"17","author":[{"given":"Chengcong","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Emergency, Nanhu District People\u2019s Hospital","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nanhu District People\u2019s Hospital","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Nanhu District People\u2019s Hospital","place":["Jiaxing, Zhejiang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/noab269","article-title":"Cancer cell heterogeneity and plasticity: a paradigm shift in glioblastoma","volume":"24","author":"Al-Dalahmah","year":"2022","journal-title":"Neuro Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.3390\/ijms23136879","article-title":"Ferroptosis modulation: potential therapeutic target for glioblastoma treatment","volume":"23","author":"Alves da Costa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B4","first-page":"1397","article-title":"Expression of the genes encoding myelin basic protein and proteolipid protein in human malignant gliomas","volume":"49","author":"He","year":"1995","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11912-018-0673-2","article-title":"Single-cell RNA-sequencing in glioma","volume":"18","author":"Johnson","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B23","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/s41467-021-21117-3","article-title":"Tumor cell plasticity, heterogeneity, and resistance in crucial microenvironmental niches in glioma","volume":"12","author":"Jung","year":"2021","journal-title":"Nat. Commun."},{"key":"B6","doi-asserted-by":"publisher","first-page":"13616","DOI":"10.1038\/ncomms13616","article-title":"Targeting the Notch-regulated non-coding RNA TUG1 for glioma treatment","volume":"7","author":"Katsushima","year":"2016","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"17267","DOI":"10.1038\/srep17267","article-title":"Quantifying the heritability of glioma using genome-wide complex trait analysis","volume":"5","author":"Kinnersley","year":"2015","journal-title":"Sci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1158\/1055-9965.EPI-17-1080","article-title":"Genome-Wide Association studies in Glioma","volume":"27","author":"Kinnersley","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.semcancer.2021.02.014","article-title":"Cancer cell heterogeneity and plasticity in glioblastoma and brain tumors","volume":"82","author":"Lauko","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1396836","DOI":"10.3389\/fcell.2024.1396836","article-title":"Advancing precision medicine in gliomas through single-cell sequencing: unveiling the complex tumor microenvironment","volume":"12","author":"Li","year":"2024","journal-title":"Front. Cell Dev. Biol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13062-020-00264-5","article-title":"Computational identification and characterization of glioma candidate biomarkers through multi-omics integrative profiling","volume":"15","author":"Liu","year":"2020","journal-title":"Biol. Direct"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3390\/antiox11112123","article-title":"Ferroptosis and its potential role in glioma: from molecular mechanisms to therapeutic opportunities","volume":"11","author":"Luo","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1158\/2159-8290.CD-20-1474","article-title":"Diffuse glioma heterogeneity and its therapeutic implications","volume":"11","author":"Mackay","year":"2021","journal-title":"Cancer Discov."},{"key":"B13","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1038\/ng.3823","article-title":"Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors","volume":"49","author":"Melin","year":"2017","journal-title":"Nat. Genet."},{"key":"B14","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.cell.2019.06.024","article-title":"An integrative model of cellular States, plasticity, and genetics for glioblastoma","volume":"178","author":"Neftel","year":"2019","journal-title":"Cell"},{"key":"B15","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/noz150","article-title":"CBTRUS statistical report: primary brain and other central nervous System tumors diagnosed in the United States in 2012-2016","volume":"21","author":"Ostrom","year":"2019","journal-title":"Neuro Oncol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1126\/science.1254257","article-title":"Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma","volume":"344","author":"Patel","year":"2014","journal-title":"Science"},{"key":"B17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","article-title":"Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization","volume":"24","author":"Pombo Antunes","year":"2021","journal-title":"Nat Neurosci"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00439-012-1212-0","article-title":"Genome-wide association study of glioma and meta-analysis","volume":"131","author":"Rajaraman","year":"2012","journal-title":"Hum. Genet."},{"key":"B19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccell.2022.05.009","article-title":"Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma","volume":"40","author":"Ravi","year":"2022","journal-title":"Cancer Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"key":"B21","doi-asserted-by":"publisher","first-page":"11779322241249563","DOI":"10.1177\/11779322241249563","article-title":"Integration of multi-omics data for the classification of glioma types and identification of novel biomarkers","volume":"18","author":"Vieira","year":"2024","journal-title":"Bioinform Biol. Insights"},{"key":"B22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.61189\/691939hefazb","article-title":"The role and research progress of ferroptosis in myocardial injury in sepsis","volume":"3","author":"Wang","year":"2025","journal-title":"Perioper. Precis. Med."},{"key":"B24","first-page":"285","article-title":"Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma","volume":"41","author":"Yuan","year":"2023","journal-title":"Cancer Cell"},{"key":"B25","first-page":"1638","article-title":"Ferroptosis-related gene signature predicts glioma cell death and glioma patient progression","volume":"10","author":"Zhang","year":"2020","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1818742\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T22:10:27Z","timestamp":1779919827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2026.1818742\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":25,"alternative-id":["10.3389\/fgene.2026.1818742"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2026.1818742","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"article-number":"1818742"}}